Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial.

Autor: Vigneswaran HT; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Urology, University of Illinois at Chicago, Chicago, IL., Eklund M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Discacciati A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Nordström T; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Hubbard RA; Department of Biostatistics, Epidemiology & Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Perlis N; Department of Surgery, University of Toronto, University Health Network, Toronto, Canada., Abern MR; Department of Urology, University of Illinois at Chicago, Chicago, IL.; Department of Surgery, Duke University School of Medicine, Durham, NC., Moreira DM; Department of Urology, University of Illinois at Chicago, Chicago, IL., Eggener S; Department of Surgery, University of Chicago, Chicago, IL., Yonover P; Uropartners, LLC, Westchester, IL., Chow AK; Department of Urology, Rush University Medical Center, Chicago, IL., Watts K; Department of Urology, Montefiore Medical Center, Bronx, NY., Liss MA; Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX., Thoreson GR; Urology Clinics of North Texas, Dallas, TX., Abreu AL; Institute of Urology, University of Southern California Keck School of Medicine Los Angeles, CA., Sonn GA; Department of Urology, Stanford University School of Medicine, Palo Alto, CA., Palsdottir T; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Plym A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Wiklund F; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Grönberg H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Murphy AB; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Nov 10; Vol. 42 (32), pp. 3806-3816. Date of Electronic Publication: 2024 Jul 22.

Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonists.

Autor: Björnebo L; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Razdan S; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Discacciati A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Palsdottir T; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Aly M; Department of Urology, Karolinska University Hospital Solna, Stockholm, Sweden., Nordström T; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Eklund M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Lundon D; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Grönberg H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Tewari A; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Oncological Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Wiklund P; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Kyprianou N; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Oncological Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Lantz A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Urology, Karolinska University Hospital Solna, Stockholm, Sweden.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Sep 01; Vol. 116 (9), pp. 1459-1465.

The Capio Prostate Cancer Center Model for Prostate Cancer Diagnostics-Real-world Evidence from 2018 to 2022.

Autor: Palsdottir T; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden., Söderbäck H; Department of Oncology, Capio St. Görans Sjukhus, Stockholm, Sweden., Jäderling F; Department of Oncology, Capio St. Görans Sjukhus, Stockholm, Sweden., Bergman M; Urokirurgist Centrum, Capio, Stockholm, Sweden., Vigneswaran H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden., Grönberg H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden.; Department of Oncology, Capio St. Görans Sjukhus, Stockholm, Sweden.

Publikováno v: European urology open science [Eur Urol Open Sci] 2024 Feb 06; Vol. 61, pp. 29-36. Date of Electronic Publication: 2024 Feb 06 (Print Publication: 2024).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.